이지다이아텍

메뉴 건너뛰기
사이트맵 건너뛰기
콘텐츠 시작

Obtained Certification of VEUPLEX™ TBI assay from the Korea Ministry of Food and Drug Safety



Ezdiatech Inc., a company specializing in in vitro diagnostics, has obtained domestic approval from the Korea Ministry of Food and Drug Safety
for its innovative diagnostic reagent, ‘VEUPLEX™ TBI assay,’ designed for
diagnosing traumatic brain injury (TBI).

PREV
2024 The Korean Society of Emergency Medicine Spring Conference (Interburgo Hotel, Daegu)
NEXT
Acquisition of New Excellent Technology (NET) certification in the field of chemical life sciences